For Industry.
Cooperating in finding solutions for patients.
WHAT CAN EMHA DO FOR THE INDUSTRY.
Cooperating in finding solutions for patients.
Working together is the only way to find effective and lasting solutions for migraine sufferers.
By encouraging research, supporting projects and working to distribute reliable information, we can achieve a better quality of life for all patients living with migraine.
EMHA PROJECTS
Raising awareness to change the future under #TheMigraineMovement
Stigma survey 2023
Migraine & Stigma Survey 2023 In 2023, the EMHA conducted a comprehensive pan-European digital survey answered by 4.210 people across 17 countries. In order to examinate the origins of stigma surrounding migraine, its impact on patients, and their need for better understanding and support. The survey covers various topics such as patients’ ease in sharing
Women at work
In 2018 EMHA organised a survey among migraine patients working in 7 EU countries (Ireland, Italy, France, Germany, Portugal, Spain and United Kingdom.
The survey shed light on how women have to juggle between migraine attacks and work.
The Migraine Assistant
After launching The Migraine Movement Manifesto, from EMHA, we set the goal to inform the largest amount of European migraine sufferers about the existence of that movement, born with the aim of giving them visibility, answers and support.
Explaining Migraine
We realized that the words we normally use to describe our relationship with migraine simply fall short to convey the true feeling behind. Words like “pain” or “horror”, commonly used to describe a migraine, ended up being generic adjectives that linked our disease to a simple headache.
The Missing Lesson
The lack of medical training is the main barrier for an accurate diagnosis when a possible migraine patient first visits a doctor. In the world, only 4 hours of migraine are studied in medical training.
COLLABORATIVE SUPPORTERS GUIDELINES
Working with the pharmaceutical and biotech industries.
Cooperate to improve the life quality of all the migraine sufferers community.
Abbvie
Curelator
Grunenthal
Ipsen
Lundbeck
Novartis
Organon
Pfizer
Teva
COLLABORATORS
We have the support of all of them.
VISIT AHMA
ANNUAL REPORT
EMHA Activities Report 2023
EMHA’s agenda of 2023 was filled with trips, meetings and events that put migraine on the agenda of European’s and worldwide organizations and policy makers.